| |
|
|
|
Tenax Therapeutics  
|
|
6.11 0.11 (0.02%) |
05-25 16:00 |
|
Open: |
6.0068 |
Pre close: |
6 |
Target:
|
7.74
|
|
High: |
6.18 |
Low: |
5.9313 |
Resistance:
|
6.63
7.19
|
|
Volume: |
22,228 |
Market Cap: |
9M |
Support:
|
5.72
4.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.97
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
6.17  |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
6.83 |
Stochastic Oscillator |
%K(14,3):
|
20.86 |
|
MA(250): |
8.28 |
%D(3): |
16.64 |
|
Average Volume(K) |
3-Month: |
25025
|
52-Week |
High:
|
15.80 |
|
10-Days: |
3051 |
Low: |
4.41 |
|
RSI |
RSI(14):
|
47.15 |
Change(%): |
-39.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-67.9 |
Shares Out. (M) |
1.45 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-53.2 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.00 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
158 |
|
Book Value (p.s.) |
1.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.14 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.34 |
P/CF |
-0.73 |
|
|
|
|
|
|
